Narrative review / 2008
Bariatric surgery produces durable weight loss, high rates of type 2 diabetes remission, and reduced mortality with low 90-day operative mortality.
This review evaluates the safety and efficacy of bariatric surgery, focusing on adjustable gastric banding, gastric bypass, and biliopancreatic bypass with duodenal switch in individuals with severe obesity. Controlled randomized studies demonstrate durable weight loss exceeding 100 lb (46 kg), full and long-term remission of type 2 diabetes in over 80%, beneficial effects on other comorbidities, and significant reductions in all-cause mortality. In U.S. Centers of Excellence, the 90-day surgical mortality rate is 0.35%, comparable to complication rates seen after cholecystectomy.
- Study type
- Review
- Who was studied
- Individuals with severe obesity (body mass index >35 kg/m2)
- What was measured
- Weight loss, remission of comorbidities, all-cause mortality, and surgical complications/safety
THE PAPER
Bariatric surgery: risks and rewards.
Pories WJ. J Clin Endocrinol Metab, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.